Skip to main content

Table 5 Concurrent infection with other fungi or bacteria in patients with COPD

From: Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay

 

Patients with concurrent infection

Patients without concurrent infection

Total

Positive rate (%)

AECOPD

56

162

218

25.69*

COPD Stable stage

10

20

30

33.33

Total

66

182

248

36.26

  1. *P > 0.05 compared with concurrent infection with fungi or bacteria among COPD patients in stable stage